Enzo Biochem Stock Performance
| ENZ Stock | USD 0.61 0.01 1.67% |
The firm shows a Beta (market volatility) of 2.13, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Enzo Biochem will likely underperform. At this point, Enzo Biochem has a negative expected return of -0.73%. Please make sure to confirm Enzo Biochem's value at risk and rate of daily change , to decide if Enzo Biochem performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Enzo Biochem has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Forward Dividend Yield 0.396 | Last Split Factor 105:100 | Forward Dividend Rate 0.4 | Dividend Date 2024-12-02 | Ex Dividend Date 2024-11-15 |
1 | Will Enzo Biochem Spend Its Cash Wisely | 11/19/2024 |
2 | Insider Trading | 11/22/2024 |
| Enzo Biochem dividend paid on 2nd of December 2024 | 12/02/2024 |
3 | The Zacks Analyst Blog Highlights Amgen, Eaton, Sony, iMage and Enzo Biochem | 12/05/2024 |
4 | Enzo Biochem Fiscal Q1 Earnings Snapshot | 12/16/2024 |
5 | Enzo Biochem First Quarter 2025 Earnings US0.059 loss per share | 12/18/2024 |
6 | Zelensky vows no forgiveness for Putin, expects Trump to achieve peace through strength | 01/06/2025 |
7 | Sirona Biochem Showcases TFC-1326 in Stonegate Healthcares Landmark Report | 01/15/2025 |
8 | Enzo Biochem Receives Notice from NYSE Regarding Listing ComplianceFarmingdale, NY Enzo Biochem, Inc. recently disclosed that it received a notice from the New ... | 01/16/2025 |
9 | Enzo Biochem stock hits 52-week low at 0.63 amid market challenges - Investing.com | 01/27/2025 |
| Begin Period Cash Flow | 83.4 M |
Enzo |
Enzo Biochem Relative Risk vs. Return Landscape
If you would invest 103.00 in Enzo Biochem on November 3, 2024 and sell it today you would lose (42.00) from holding Enzo Biochem or give up 40.78% of portfolio value over 90 days. Enzo Biochem is generating negative expected returns assuming volatility of 4.6512% on return distribution over 90 days investment horizon. In other words, 41% of stocks are less volatile than Enzo, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Enzo Biochem Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Enzo Biochem's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Enzo Biochem, and traders can use it to determine the average amount a Enzo Biochem's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1568
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ENZ |
Estimated Market Risk
| 4.65 actual daily | 41 59% of assets are more volatile |
Expected Return
| -0.73 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.16 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Enzo Biochem is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Enzo Biochem by adding Enzo Biochem to a well-diversified portfolio.
Enzo Biochem Fundamentals Growth
Enzo Stock prices reflect investors' perceptions of the future prospects and financial health of Enzo Biochem, and Enzo Biochem fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Enzo Stock performance.
| Return On Equity | -0.15 | ||||
| Return On Asset | -0.0744 | ||||
| Profit Margin | (0.82) % | ||||
| Operating Margin | (0.39) % | ||||
| Current Valuation | (12.81 M) | ||||
| Shares Outstanding | 52.24 M | ||||
| Price To Earning | 26.60 X | ||||
| Price To Book | 0.66 X | ||||
| Price To Sales | 0.99 X | ||||
| Revenue | 31.91 M | ||||
| Gross Profit | 14.63 M | ||||
| EBITDA | (8.35 M) | ||||
| Net Income | (26.08 M) | ||||
| Cash And Equivalents | 82.37 M | ||||
| Cash Per Share | 0.44 X | ||||
| Total Debt | 3.51 M | ||||
| Debt To Equity | 0.38 % | ||||
| Current Ratio | 2.21 X | ||||
| Book Value Per Share | 1.07 X | ||||
| Cash Flow From Operations | (26.26 M) | ||||
| Earnings Per Share | (0.15) X | ||||
| Market Capitalization | 31.65 M | ||||
| Total Asset | 85.76 M | ||||
| Retained Earnings | (294.43 M) | ||||
| Working Capital | 45.24 M | ||||
| Current Asset | 91.4 M | ||||
| Current Liabilities | 20.57 M | ||||
About Enzo Biochem Performance
Evaluating Enzo Biochem's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Enzo Biochem has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Enzo Biochem has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 166.00 | 85.69 | |
| Return On Tangible Assets | (0.35) | (0.33) | |
| Return On Capital Employed | (0.19) | (0.18) | |
| Return On Assets | (0.35) | (0.33) | |
| Return On Equity | (0.42) | (0.44) |
Things to note about Enzo Biochem performance evaluation
Checking the ongoing alerts about Enzo Biochem for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Enzo Biochem help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Enzo Biochem generated a negative expected return over the last 90 days | |
| Enzo Biochem has some characteristics of a very speculative penny stock | |
| Enzo Biochem has high historical volatility and very poor performance | |
| The company reported the last year's revenue of 31.91 M. Reported Net Loss for the year was (26.08 M) with profit before taxes, overhead, and interest of 14.63 M. | |
| Enzo Biochem has about 82.37 M in cash with (26.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.44. | |
| Roughly 22.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Enzo Biochem stock hits 52-week low at 0.63 amid market challenges - Investing.com |
- Analyzing Enzo Biochem's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Enzo Biochem's stock is overvalued or undervalued compared to its peers.
- Examining Enzo Biochem's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Enzo Biochem's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Enzo Biochem's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Enzo Biochem's stock. These opinions can provide insight into Enzo Biochem's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Enzo Stock Analysis
When running Enzo Biochem's price analysis, check to measure Enzo Biochem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enzo Biochem is operating at the current time. Most of Enzo Biochem's value examination focuses on studying past and present price action to predict the probability of Enzo Biochem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enzo Biochem's price. Additionally, you may evaluate how the addition of Enzo Biochem to your portfolios can decrease your overall portfolio volatility.